Clinical Trials for Recurrent Cancer

Find clinical trials for recurrent cancer. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

Personalized Neoantigen Peptide Vaccines for Solid Tumors

NCT ID: NCT07002203

This clinical trial is exploring a new personalized cancer treatment called a neoantigen peptide vaccine for patients with solid tumors, which are types of cancer that form in tissues or organs. Th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bangkok, , Thailand, Bangkok, , Thailand

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor

NCT ID: NCT05359445

This clinical trial is studying a new treatment called IMA401 for adults with advanced solid tumors that have either come back after treatment or have not responded to standard therapies. The main ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Münster, , Germany, Freiburg, Baden Württemberg, Germany +37 more

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

NCT ID: NCT04421560

This clinical trial is exploring a new treatment approach for patients with recurrent primary central nervous system lymphoma (PCNSL), a type of cancer that affects the brain and spinal cord. The s...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, New York, New York, United States +2 more

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

NCT ID: NCT03686124

This clinical trial, called ACTengine® IMA203/IMA203CD8, is researching a new treatment for adults with solid tumors that are difficult to treat, specifically those that keep coming back or have no...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Philadelphia, Pennsylvania, United States +15 more

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

NCT ID: NCT05958121

This clinical trial is studying a new treatment called IMA402, designed to help patients with recurrent or hard-to-treat solid tumors. The main goals are to find the highest dose that is safe to us...

Recruiting

Phase: PHASE1 Type: interventional Locations: Groningen, , Netherlands, Utrecht, , Netherlands +20 more

Study of CEA Targeting CAR-T in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

NCT ID: NCT06821048

This clinical trial is studying a new treatment called CAR-T therapy, which uses specially modified immune cells to target and fight certain types of advanced cancers that are positive for a protei...

Recruiting

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

NCT ID: NCT06208657

The clinical trial titled "Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer" is focused on finding new treatment options for children and young adults with specific ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, South Australia, Australia, Melbourne, Victoria, Australia +10 more

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

NCT ID: NCT04204850

This clinical trial is studying a new drug called cabozantinib to see how well it works in treating patients with liver cancer that has come back after a liver transplant. The type of cancer being ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Toronto, Ontario, Canada

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

NCT ID: NCT06644846

This clinical trial is looking at a special type of radiation treatment called spatially fractionated radiation therapy (RT) for women with cervical cancer or pelvic recurrences. The goal is to see...

Not yet recruiting

Phase: NA Type: interventional

PREventing Second Cancers With DOSTARlimab

NCT ID: NCT05855811

The PREventing Second Cancers With DOSTARlimab (PredoSTAR) clinical trial is exploring whether a medication called dostarlimab can help prevent second cancers in patients who are at high risk after...

Recruiting

Phase: PHASE2 Type: interventional Locations: Villejuif, , France, Toulouse, , France +3 more

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

NCT ID: NCT05415475

This clinical trial is exploring a new treatment called CAR-T cell therapy for patients with advanced cancers that are positive for a marker called CEA. The trial is specifically looking at patient...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jinan, Shandong, China, Jinan, Shandong, China +1 more

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

NCT ID: NCT05189054

This clinical trial is studying a treatment called Stereotactic Body Radiation Therapy (SBRT) for patients with recurrent thoracic tumors that are hard to treat. These tumors, known as "ultra-centr...

Recruiting

Type: observational Locations: Beijing, Beijing, China, Beijing, Beijing, China

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT ID: NCT04889742

This clinical trial is studying a new treatment approach for patients with recurrent cancer who have already received radiation therapy in the past. The researchers want to see if using heat (calle...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Berlin, , Germany

Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer

NCT ID: NCT06103617

This clinical trial is studying the safety and effectiveness of a medication called penicillamine in helping patients with recurrent head and neck cancer respond better to radiation therapy. Resear...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China, Guangzhou, , China

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

NCT ID: NCT05626829

This clinical trial is studying the use of a medication called Tranilast to help make radiotherapy (a common treatment for nasopharyngeal carcinoma, a type of head and neck cancer) more effective f...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse

NCT ID: NCT04784221

This clinical trial is looking at a new treatment method for patients with recurrent cancer who have already received radiation therapy in the past. The study will use a special type of radiation c...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions